Access the full text.
Sign up today, get DeepDyve free for 14 days.
Erika Lee, Feng Yue, Richard Jones, Calvin Lo, P. Sheth, Martin Hyrcza, Colin Kovacs, E. Benko, Rupert Kaul, Mario Ostrowski (2010)
The impact of CCL3L1 copy number in an HIV-1-infected white populationAIDS, 24
Susanne Eriksson, E. Graf, V. Dahl, M. Strain, S. Yukl, E. Lysenko, R. Bosch, J. Lai, S. Chioma, Fatemeh Emad, M. Abdel-Mohsen, R. Hoh, F. Hecht, P. Hunt, M. Somsouk, J. Wong, Rowena Johnston, R. Siliciano, D. Richman, U. O’Doherty, S. Palmer, S. Deeks, J. Siliciano (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication StudiesPLoS Pathogens, 9
J. Hoxie, C. June (2012)
Novel cell and gene therapies for HIV.Cold Spring Harbor perspectives in medicine, 2 10
T. Chun, L. Carruth, D. Finzi, Xuefei Shen, Joseph DiGiuseppe, H. Taylor, M. Heřmánková, K. Chadwick, J. Margolick, T. Quinn, Y. Kuo, R. Brookmeyer, M. Zeiger, P. Barditch‐Crovo, R. Siliciano (1997)
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 387
E. Graf, A. Mexas, Jianqing Yu, F. Shaheen, M. Liszewski, M. Mascio, S. Migueles, M. Connors, U. O’Doherty (2011)
Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAARTPLoS Pathogens, 7
(2010)
Long-term immunoviro- logic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
T. Chun, L. Stuyver, S. Mizell, L. Ehler, J. Mican, M. Baseler, A. Lloyd, M. Nowak, A. Fauci (1997)
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.Proceedings of the National Academy of Sciences of the United States of America, 94 24
Daniel Mendoza, Sarah Johnson, Bennett Peterson, V. Natarajan, M. Salgado, R. Dewar, P. Burbelo, N. Doria-Rose, E. Graf, Jamieson Greenwald, Jessica Hodge, W. Thompson, Nancy Cogliano, Cheryl Chairez, C. Rehm, Sara Jones, C. Hallahan, J. Kovacs, I. Sereti, O. Sued, S. Peel, R. O’Connell, U. O’Doherty, T. Chun, M. Connors, S. Migueles (2012)
Comprehensive analysis of unique cases with extraordinary control over HIV replication.Blood, 119 20
S. Lewin, C. Rouzioux (2011)
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?AIDS, 25
S. Butler, M. Hansen, F. Bushman (2001)
A quantitative assay for HIV DNA integration in vivoNature Medicine, 7
Jianqing Yu, Te-Lang Wu, M. Liszewski, J. Dai, W. Swiggard, Clifford Baytop, I. Frank, B. Levine, Wei Yang, Theodore Theodosopoulos, U. O’Doherty (2008)
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.Virology, 379 1
Christine Hogan, Christine Hogan, V. DeGruttola, Xin Sun, S. Fiscus, C. Rio, C. Hare, M. Markowitz, E. Connick, B. Macatangay, K. Tashima, Beatrice Kallungal, R. Camp, Tia Morton, E. Daar, S. Little (2012)
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.The Journal of infectious diseases, 205 1
K. Koelsch, C. Boesecke, K. McBride, L. Gelgor, P. Fahey, V. Natarajan, D. Baker, M. Bloch, J. Murray, J. Zaunders, S. Emery, D. Cooper, A. Kelleher (2011)
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoirAIDS, 25
J. Wong, M. Hezareh, H. Günthard, D. Havlir, C. Ignacio, C. Spina, D. Richman (1997)
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science, 278 5341
J. Siliciano, Joleen Kajdas, D. Finzi, T. Quinn, K. Chadwick, J. Margolick, C. Kovacs, S. Gange, R. Siliciano (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cellsNature Medicine, 9
(2008)
A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in anti-retroviral therapy treated patients
A. Brussel, P. Sonigo (2003)
Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated ProvirusJournal of Virology, 77
E. Hamlyn, F. Ewings, K. Porter, D. Cooper, G. Tambussi, M. Schechter, C. Pedersen, J. Okulicz, M. Mcclure, A. Babiker, J. Weber, S. Fidler (2012)
Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV InfectionPLoS ONE, 7
R. Mayeux, Y. Stern (2012)
Epidemiology of Alzheimer disease.Cold Spring Harbor perspectives in medicine, 2 8
T. Chun, A. Fauci (2012)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cureAIDS, 26
U. O’Doherty, W. Swiggard, D. Jeyakumar, D. McGain, M. Malim (2002)
A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 IntegrationJournal of Virology, 76
M. Liszewski, Jianqing Yu, U. O’Doherty (2009)
Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR.Methods, 47 4
K. Koelsch, Lin Liu, R. Haubrich, S. May, D. Havlir, H. Günthard, C. Ignacio, Paula Campos-Soto, S. Little, R. Shafer, G. Robbins, R. D’Aquila, Y. Kawano, Karen Young, Phillip Dao, C. Spina, D. Richman, J. Wong (2008)
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.The Journal of infectious diseases, 197 3
M. Strain, S. Little, E. Daar, D. Havlir, H. Gunthard, R. Lam, O. Daly, Juin Nguyen, C. Ignacio, C. Spina, D. Richman, J. Wong (2005)
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.The Journal of infectious diseases, 191 9
This is the first clinical trial of IFN-a to show a reduction in reservoir size, as measured by integrated HIV DNA
A. Mexas, E. Graf, M. Pace, Jianqing Yu, E. Papasavvas, L. Azzoni, M. Busch, M. Mascio, A. Foulkes, S. Migueles, L. Montaner, U. O’Doherty (2012)
Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trialsAIDS, 26
T. Chun, D. Murray, J. Justement, C. Hallahan, S. Moir, C. Kovacs, A. Fauci (2011)
Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.The Journal of infectious diseases, 204 1
J. Murray, K. McBride, C. Boesecke, M. Bailey, J. Amin, Kazuo Suzuki, D. Baker, J. Zaunders, S. Emery, D. Cooper, K. Koelsch, A. Kelleher (2012)
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwardsAIDS, 26
D. Finzi, M. Heřmánková, T. Pierson, L. Carruth, C. Buck, R. Chaisson, T. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. Ho, D. Richman, R. Siliciano (1997)
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.Science, 278 5341
L. Trautmann, F. Mbitikon-Kobo, J. Goulet, Yoav Peretz, Yu Shi, J. Grevenynghe, F. Procopio, M. Boulassel, J. Routy, N. Chomont, E. Haddad, R. Sékaly (2012)
Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection.Blood, 120 17
C. Goujard, D. Émilie, C. Roussillon, V. Godot, C. Rouzioux, A. Venet, Céline Colin, G. Pialoux, P. Girard, V. Boilet, M. Chaix, P. Galanaud, G. Chêne (2012)
Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM TrialAIDS, 26
L. Azzoni, A. Foulkes, E. Papasavvas, A. Mexas, K. Lynn, K. Mounzer, P. Tebas, J. Jacobson, I. Frank, M. Busch, S. Deeks, M. Carrington, U. O’Doherty, J. Kostman, L. Montaner (2013)
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.The Journal of infectious diseases, 207 2
C. Goujard, I. Girault, C. Rouzioux, C. Lécuroux, C. Deveau, M. Chaix, C. Jacomet, A. Talamali, J. Delfraissy, A. Venet, L. Meyer, M. Sinet (2012)
Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of TherapyAntiviral Therapy, 17
S. Yukl, S. Yukl, Sara Gianella, S. Gianella, E. Sinclair, L. Epling, Qingsheng Li, L. Duan, Alex Choi, Alex Choi, V. Girling, T. Ho, Peilin Li, Peilin Li, K. Fujimoto, K. Fujimoto, H. Lampiris, H. Lampiris, C. Hare, M. Pandori, A. Haase, H. Günthard, M. Fischer, A. Shergill, A. Shergill, K. Mcquaid, K. Mcquaid, D. Havlir, J. Wong, J. Wong (2010)
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.The Journal of infectious diseases, 202 10
N. Chomont, M. El-Far, P. Ancuța, L. Trautmann, F. Procopio, B. Yassine-Diab, G. Boucher, M. Boulassel, G. Ghattas, J. Brenchley, T. Schacker, Brenna Hill, D. Douek, J. Routy, E. Haddad, R. Sékaly (2009)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 15
L. Agosto, M. Liszewski, A. Mexas, E. Graf, M. Pace, Jianqing Yu, A. Bhandoola, U. O’Doherty (2011)
Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.Virology, 409 1
Evelyn Eisele, R. Siliciano (2012)
Redefining the viral reservoirs that prevent HIV-1 eradication.Immunity, 37 3
Steven Chu, S. Deeks, B. Autran, B. Berkhout, M. Benkirane, S. Cairns, N. Chomont, T. Chun, M. Churchill, M. Mascio, C. Katlama, A. Lafeuillade, A. Landay, M. Lederman, S. Lewin, F. Maldarelli, D. Margolis, M. Markowitz, J. Martinez-Picado, J. Mullins, J. Mellors, S. Moreno, U. O’Doherty, S. Palmer, M. Penicaud, M. Peterlin, G. Poli, J. Routy, C. Rouzioux, G. Silvestri, M. Stevenson, A. Telenti, C. Lint, E. Verdin, A. Woolfrey, J. Zaia, F. Barré-Sinoussi (2012)
Towards an HIV cure: a global scientific strategyNature Reviews Immunology, 12
REVIEW URRENT Quantitation of integrated proviral DNA in PINION viral reservoirs Erin H. Graf and Una O’Doherty Purpose of review Integrated HIV DNA can give rise to infectious virus, and therefore may be a surrogate of reservoir size. How this form reflects the amount of replication competent virus in vivo remains to be established. This review highlights the technical hurdles involved in measuring integrated HIV DNA, progress toward overcoming these hurdles by repetitive sampling and recent important in-vivo findings monitoring this HIV DNA intermediate. Recent findings The dynamics of integration levels after antiretroviral therapy may provide clues to how reservoirs accumulate over time and why early intervention may be beneficial. Recent studies including a multilab collaboration showed that integrated HIV DNA correlate with several viral DNA intermediates including replication competent virus as measured by a quantitative coculture assay. Because this assay performs robustly over a large dynamic range and is reproducible, it may be useful for detecting small changes in reservoir size in trials that target reservoirs as suggested by a recent trial with interferon-a. Summary Integrated HIV DNA provides an important surrogate for reservoir size and may be useful in trials that target HIV reservoirs. By performing large
Current Opinion in HIV and Aids – Wolters Kluwer Health
Published: Mar 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.